The Patent Finder

Terms ending in 2032

AstraZeneca AB

Every in-force patent on AstraZeneca AB's record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 8,895,570Purine Derivatives
In force
 · High confidence
Sumitomo Pharma Co., Ltd.In forceHigh confidence
US 9,402,847Combinations Comprising (S)-4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 8,748,603Crystalline Forms of N-[2-[[(2,3-Difluorophenyl)METHYL]THIO]-6-{[(1R,2S)-2,3-Dihydroxy-1-Methylpropyl]OXY}-4-Pyrimidinyl]-1-Azetidinesulfonamide
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 9,079,873Process for the Preparation of Benzyl [(3aS,4R,6S,6aR)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol]-4-yl]carbamate and Intermediates in the Process
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 8,894,970Arginase Inhibitors and Methods of Use Thereof
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 9,732,0582-(2,4,5-Substituted-ANILINO)PYRIMIDINE Compounds
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 10,017,4932-(2,4,5-Substituted-ANILINO)PYRIMIDINE Compounds
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 10,858,3362-(2,4,5-Substituted-ANILINO)PYRIMIDINE Compounds
In force
 · Medium confidence
AstraZeneca ABIn forceMedium confidence
US 11,524,9512-(2,4,5-Substituted-ANILINO)PYRIMIDINE Compounds
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 8,771,648(TRIMETHOXYPHENYLAMINO) Pyrimidinyl Formulations
In force
 · High confidence
Rigel Pharmaceuticals, Inc.In forceHigh confidence
8 more term ends in 2032 · Pro
10 of 18 patents shown. Soonest term end first, then patent number.
Pro members see all 18.
Upgrade to Pro
13 of these are in force and held by AstraZeneca AB.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited